
Biocon Limited has informed the Exchange regarding a press release dated November 15, 2021, titled "Biocon Biologics Collaborates with RSSDI to Expand Access to its Insulins for Children with Type 1 Diabetes on World Diabetes Day".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated November 15, 2021, titled "Biocon Biologics Collaborates with RSSDI to Expand Access to its Insulins for Children with Type 1 Diabetes on World Diabetes Day".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon